Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIC/FTC/TAF”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Post-approval studies (Phase 4)Looking for participantsNCT07138144
What this trial is testing

Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up

Who this might be right for
HIV Infections
José Antonio Mata Marín 156
Post-approval studies (Phase 4)Looking for participantsNCT07031063
What this trial is testing

Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience

Who this might be right for
HIV InfectionMetabolic SyndromeAntiretroviral Treatment
Instituto Mexicano del Seguro Social 124
Post-approval studies (Phase 4)UnknownNCT04222283
What this trial is testing

Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication

Who this might be right for
HIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 27
Large-scale testing (Phase 3)Looking for participantsNCT07266831
What this trial is testing

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC 570
Testing effectiveness (Phase 2)Study completedNCT04564547
What this trial is testing

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 161
Post-approval studies (Phase 4)Study completedNCT04884139
What this trial is testing

DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:

Who this might be right for
HIV-1-infection
Fundacion SEIMC-GESIDA 554
Not applicableStudy completedNCT06518213
What this trial is testing

Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

Who this might be right for
HIV Infections
University Hospital for Infectious Diseases, Croatia 112
Post-approval studies (Phase 4)UnknownNCT04993872
What this trial is testing

Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF

Who this might be right for
HIV-infected Patient Kidney Transplant Recipient
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 5
Post-approval studies (Phase 4)Study completedNCT05549180
What this trial is testing

Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities

Who this might be right for
HIV Infections
Fundacion SEIMC-GESIDA 84
Post-approval studies (Phase 4)Study completedNCT03502005
What this trial is testing

Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1

Who this might be right for
Human Immunodeficiency Virus
Midland Research Group, Inc. 100
Early research (Phase 1)Study completedNCT04244448
What this trial is testing

Bioequivalence of Solid/Crushed/Dissolved Forms of Biktarvy®

Who this might be right for
Healthy Volunteers
University Hospital, Caen 18
Not applicableUnknownNCT04712058
What this trial is testing

Same-day Antiretroviral Therapy With BIC/F/TAF

Who this might be right for
HIV Infections
National Taiwan University Hospital 200
Post-approval studies (Phase 4)Study completedNCT05606055
What this trial is testing

The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection

Who this might be right for
HIV-1-infection
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 100
Post-approval studies (Phase 4)Study completedNCT04530630
What this trial is testing

Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant

Who this might be right for
HIV InfectionsRenal Transplant Rejection
Weill Medical College of Cornell University 20
Large-scale testing (Phase 3)Looking for participantsNCT07075146
What this trial is testing

DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity

Who this might be right for
HIV - Human Immunodeficiency VirusObesityOverweight and/or Obesity
José Antonio Mata Marín 306
Not applicableStudy completedNCT07004933
What this trial is testing

Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID)

Who this might be right for
HIV Positive People Who Inject Drugs
Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases 37
Large-scale testing (Phase 3)WithdrawnNCT05457530
What this trial is testing

Doravirine and Weight Gain in Antiretroviral Naive

Who this might be right for
Body Weight ChangesHuman Immunodeficiency VirusART+5 more
Prism Health North Texas
Large-scale testing (Phase 3)Active Not RecruitingNCT05630755
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 514
Large-scale testing (Phase 3)Study completedNCT05911360
What this trial is testing

Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF

Who this might be right for
HIVHIV Infections
ViiV Healthcare 205
Testing effectiveness (Phase 2)Active Not RecruitingNCT06891066
What this trial is testing

Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC 150
Next Page